X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6924) 6924
Newsletter (29) 29
Magazine Article (27) 27
Publication (18) 18
Dissertation (16) 16
Newspaper Article (16) 16
Book Chapter (11) 11
Book / eBook (4) 4
Web Resource (3) 3
Book Review (2) 2
Streaming Video (2) 2
Transcript (2) 2
Conference Proceeding (1) 1
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5155) 5155
enoxaparin (4362) 4362
female (2912) 2912
male (2711) 2711
anticoagulants - therapeutic use (2140) 2140
middle aged (1979) 1979
enoxaparin - therapeutic use (1854) 1854
aged (1850) 1850
prevention (1688) 1688
venous thromboembolism (1653) 1653
molecular-weight heparin (1474) 1474
adult (1374) 1374
anticoagulants - administration & dosage (1266) 1266
anticoagulants (1231) 1231
hematology (1217) 1217
enoxaparin - administration & dosage (1207) 1207
treatment outcome (1163) 1163
anticoagulants - adverse effects (1151) 1151
thromboembolism (1125) 1125
unfractionated heparin (1123) 1123
heparin (1071) 1071
surgery (1068) 1068
peripheral vascular disease (1054) 1054
risk factors (974) 974
deep-vein thrombosis (956) 956
enoxaparin - adverse effects (939) 939
thrombosis (930) 930
thromboprophylaxis (893) 893
cardiac & cardiovascular systems (817) 817
prophylaxis (815) 815
venous thromboembolism - prevention & control (791) 791
medicine, general & internal (744) 744
pharmacology & pharmacy (729) 729
aged, 80 and over (697) 697
heparin, low-molecular-weight - therapeutic use (680) 680
venous thrombosis - prevention & control (676) 676
rivaroxaban (626) 626
drug therapy (622) 622
fibrinolytic agents - therapeutic use (615) 615
hemorrhage - chemically induced (605) 605
retrospective studies (588) 588
prospective studies (553) 553
heparin - therapeutic use (542) 542
warfarin (539) 539
postoperative complications - prevention & control (532) 532
thromboembolism - prevention & control (523) 523
risk (517) 517
abridged index medicus (490) 490
time factors (483) 483
therapy (479) 479
anticoagulation (474) 474
double-blind (461) 461
pulmonary-embolism (451) 451
medicine & public health (437) 437
safety (435) 435
factor xa inhibitors (429) 429
venous thrombosis (427) 427
anticoagulants - pharmacology (417) 417
low-molecular-weight heparin (416) 416
fondaparinux (415) 415
pulmonary embolism (412) 412
dose-response relationship, drug (403) 403
enoxaparin - pharmacology (401) 401
management (393) 393
pregnancy (390) 390
animals (387) 387
analysis (386) 386
low molecular weight heparin (384) 384
care and treatment (380) 380
pharmacokinetics (377) 377
venous thromboembolism - etiology (376) 376
risk assessment (374) 374
drug administration schedule (369) 369
administration, oral (364) 364
aspirin (360) 360
venous thrombosis - drug therapy (357) 357
health aspects (352) 352
heparin, low-molecular-weight - administration & dosage (351) 351
mortality (351) 351
randomized controlled trials as topic (351) 351
orthopedics (339) 339
fibrinolytic agents - administration & dosage (337) 337
adolescent (336) 336
efficacy (335) 335
venous thrombosis - etiology (335) 335
trial (330) 330
myocardial infarction - drug therapy (329) 329
acute coronary syndromes (326) 326
follow-up studies (310) 310
drug therapy, combination (309) 309
pulmonary embolism - prevention & control (304) 304
research (304) 304
metaanalysis (300) 300
double-blind method (297) 297
complications (294) 294
arthroplasty (293) 293
dosage and administration (293) 293
incidence (293) 293
dabigatran (292) 292
heparin - adverse effects (291) 291
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6561) 6561
German (166) 166
Spanish (141) 141
French (126) 126
Russian (73) 73
Portuguese (45) 45
Italian (19) 19
Polish (18) 18
Korean (12) 12
Chinese (11) 11
Japanese (11) 11
Turkish (10) 10
Czech (8) 8
Norwegian (7) 7
Serbian (5) 5
Danish (4) 4
Ukrainian (4) 4
Persian (3) 3
Arabic (2) 2
Finnish (2) 2
Slovenian (2) 2
Bulgarian (1) 1
Croatian (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Swedish (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 14, pp. 1287 - 1297
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 15, pp. 1406 - 1415
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 358, Issue 26, pp. 2765 - 2775
Rivaroxaban is an orally administered direct inhibitor of factor Xa. As compared with enoxaparin, rivaroxaban was more effective in preventing venous... 
ORAL XIMELAGATRAN | MEDICINE, GENERAL & INTERNAL | FACTOR-XA INHIBITOR | KNEE REPLACEMENT | BAY-59-7939 | DEEP-VENOUS THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | MAJOR ORTHOPEDIC-SURGERY | DOUBLE-BLIND | PREVENTION | THROMBOEMBOLISM | Thiophenes - therapeutic use | Pulmonary Embolism - prevention & control | Venous Thromboembolism - mortality | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Male | Enoxaparin - therapeutic use | Pulmonary Embolism - epidemiology | Enoxaparin - adverse effects | Rivaroxaban | Venous Thromboembolism - prevention & control | Aged, 80 and over | Adult | Female | Venous Thrombosis - prevention & control | Morpholines - adverse effects | Morpholines - therapeutic use | Double-Blind Method | Anticoagulants - therapeutic use | Arthroplasty, Replacement, Hip | Anticoagulants - adverse effects | Venous Thrombosis - epidemiology | Adolescent | Aged | Enoxaparin | Dosage and administration | Blood coagulation factors | Comparative analysis | Health aspects | Hip joint | Clinical trials | Comparative studies | Joint surgery | Drug therapy | Clinical outcomes | Blood clots | Index Medicus | Abridged Index Medicus | Enoxaparin/adverse effects/therapeutic use | Venous Thrombosis/epidemiology/prevention & control | Thiophenes/adverse effects/therapeutic use | Arthroplasty | Replacement | Kirurgi | Hip | Morpholines/adverse effects/therapeutic use | 80 and over | Surgery | Anticoagulants/adverse effects/therapeutic use | Venous Thromboembolism/mortality/prevention & control | Factor Xa/antagonists & inhibitors | Pulmonary Embolism/epidemiology/prevention & control
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 369, Issue 9, pp. 799 - 808
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 6, pp. 513 - 523
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 363, Issue 26, pp. 2499 - 2510
In this clinical trial, rivaroxaban, an oral factor Xa inhibitor, was effective in the initial and continued treatment of symptomatic venous thromboembolism;... 
MEDICINE, GENERAL & INTERNAL | FACTOR-XA INHIBITOR | THERAPY | DISEASE | PREVENTION | DEEP-VEIN THROMBOSIS | IDRAPARINUX | Thiophenes - therapeutic use | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Middle Aged | Warfarin - adverse effects | Male | Enoxaparin - therapeutic use | Enoxaparin - adverse effects | Venous Thromboembolism - drug therapy | Warfarin - therapeutic use | Rivaroxaban | Vitamin K - antagonists & inhibitors | Injections, Subcutaneous | Female | Morpholines - adverse effects | Morpholines - therapeutic use | Acute Disease | Double-Blind Method | Venous Thrombosis - drug therapy | Administration, Oral | Kaplan-Meier Estimate | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Acenocoumarol - adverse effects | Intention to Treat Analysis | Pulmonary Embolism - drug therapy | Acenocoumarol - therapeutic use | Aged | Hemorrhage - chemically induced | Anticoagulants (Medicine) | Thromboembolism | Drug therapy | Health aspects | Risk factors | Anticoagulants | Bone surgery | Veins & arteries | Venous Thrombosis | Factor Xa | Hemorrhage | Life Sciences | Venous Thromboembolism | Thiophenes | Acenocoumarol | Vitamin K | Warfarin | Enoxaparin | Morpholines | Human health and pathology | Pulmonary Embolism | MEDICIN OCH HÄLSOVETENSKAP | Oral | MEDICAL AND HEALTH SCIENCES | Administration | chemically induced | drug therapy | Subcutaneous | antagonists & inhibitors | Injections | adverse effects | therapeutic use
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 372, Issue 9632, pp. 31 - 39